secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivani Medical, Inc. (VANI)
CIK:        0001266806
Form:       8-K
Filed at:   2025-05-29T23:59:59+00:00
Accession:  0001753926-25-000898
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivani Medical files Form 10 for spin-off of Cortigent; expects Nasdaq listing in Q3 2025
--------------------------------------------------------------------------------

- Cortigent files Form 10 to spin off from Vivani as independent Nasdaq company; completion expected Q3 2025.
- Orion Visual Cortical Prosthesis completed Early Feasibility Study in March 2025; has FDA Breakthrough Device designation.
- Cortigent advancing Stroke Recovery System to improve arm/hand movement recovery after stroke paralysis.
- Vivani will focus solely on NanoPortal GLP-1 implants for chronic weight management and type 2 diabetes.
- Spin-off requires final board approval, tax opinion, and SEC/Nasdaq clearance; shares distributed to Vivani stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1266806/000175392625000898/0001753926-25-000898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1266806/000175392625000898/vani-20250529.htm
  HTML page:      https://secwatch.observer/filing/0001753926-25-000898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer